Literature DB >> 22293809

Hypereosinophilic syndrome associated with simultaneous intracardiac thrombi, cerebral thromboembolism and pulmonary embolism.

Deram Buyuktas1, Ahmet Emre Eskazan, Sermin Borekci, Sema Umut, Zeki Ongen, Nukhet Tuzuner, Teoman Soysal.   

Abstract

The hypereosinophilic syndrome (HES) is a subcategory of idiopathic eosinophilia which is characterized by marked unexplained eosinophilia and evidence of tissue eosinophilia which leads to eosinophil-mediated organ damage. Cardiac and thromboembolic complications of HES are the common causes of mortality and morbidity. Here, we report a 54-year-old woman with HES who presented with simultaneously occurring cardiac thrombi, pulmonary embolism, and cerebrovascular thromboembolism.

Entities:  

Mesh:

Year:  2012        PMID: 22293809     DOI: 10.2169/internalmedicine.51.6156

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  A Rare Case of Aortic Valve Thrombosis in Patient with Idiopathic Hypereosinophilic Syndrome.

Authors:  Elisabetta Grolla; Michele Dalla Vestra; Luca Bonanni; Ada Cutolo; Fausto Rigo
Journal:  Case Rep Cardiol       Date:  2015-09-08

2.  Imaging diagnosis for left ventricular thrombosis in idiopathic hypereosinophilic syndrome: two case reports.

Authors:  Yu-Quan He; Ya-Nan Zhao; Jin-Ming Zhu; Meng-Chao Zhang; Lin Liu; Hong Zeng; Ping Yang
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

Review 3.  Hypereosinophilic syndrome presenting with multiple organ infiltration and deep venous thrombosis: A case report and literature review.

Authors:  Su-Jun Gao; Wei Wei; Jiang-Tao Chen; Ye-Hui Tan; Cheng-Bao Yu; Mark Robert Litzow; Qiu-Ju Liu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

4.  Application of spectral computed tomography dual-substance separation technology for diagnosing left ventricular thrombus.

Authors:  Hong Zeng; Meng-Chao Zhang; Yu-Quan He; Lin Liu; Ya-Liang Tong; Ping Yang
Journal:  J Int Med Res       Date:  2015-12-10       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.